Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
US Department of Justice
Moodys
Citi
Baxter
Healthtrust

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,799,331

« Back to Dashboard

Which drugs does patent 7,799,331 protect, and when does it expire?

Patent 7,799,331 protects FLO-PRED and is included in one NDA.

This patent has twelve patent family members in ten countries.

Summary for Patent: 7,799,331
Title:Oral suspension of prednisolone acetate
Abstract: The present invention relates to novel oral suspension formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent. The present invention further provides a method of treating patients in need of prednisolone with the novel formulation.
Inventor(s): Asotra; Satish (Brampton, CA), Gao; Shen (Botton, CA), Yacobi; Avraham (Englewood, NJ)
Assignee: Taro Pharmaceutical North America, Inc. (Grand Cayman, KY)
Application Number:11/457,197
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,799,331
Patent Claim Types:
see list of patent claims
Composition; Delivery; Use; Dosage form; Formulation;

Drugs Protected by US Patent 7,799,331

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 DISCN No No ➤ Sign Up ➤ Sign Up Y TREATMENT OF ALLERGIC REACTIONS ➤ Sign Up
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 DISCN No No ➤ Sign Up ➤ Sign Up Y TREATMENT OF ASTHMA ➤ Sign Up
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-002 Jan 17, 2008 DISCN No No ➤ Sign Up ➤ Sign Up Y TREATMENT OF ASTHMA ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Teva
McKinsey
Deloitte
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.